FY2024
Effective from
- Inherited rules changed
Immune effector cell-associated neurotoxicity syndrome, grade 3
Billable diagnosis code
CDC/NCHS · FY2024Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗Grouping depends on the complete encounter and CMS grouper logic.
2026-04-01 – 2026-09-30
CMS · MS-DRG 43.1First observed · 2021-10-01
Latest recorded change · FY2024
Effective from
Immune effector cell-associated neurotoxicity syndrome, grade 3
Billable diagnosis code
CDC/NCHS · FY2024| All editions | Effective from | Code history |
|---|---|---|
| FY2022 | 2021-10-01 | Added |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
ICANS, grade 3
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: G92
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| G92.00 | Immune effector cell-associated neurotoxicity syndrome, grade unspecified | Billable / specific |
| G92.01 | Immune effector cell-associated neurotoxicity syndrome, grade 1 | Billable / specific |
| G92.02 | Immune effector cell-associated neurotoxicity syndrome, grade 2 | Billable / specific |
| G92.04 | Immune effector cell-associated neurotoxicity syndrome, grade 4 | Billable / specific |
| G92.05 | Immune effector cell-associated neurotoxicity syndrome, grade 5 | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗